Literature DB >> 26104787

Circadian Arterial Blood Pressure Variation and Glaucoma Progression: More Questions Than Answers?

Hari Jayaram1, Luis Abegão Pinto2, Verena Prokosch3, Juliane Matlach4, Katarzyna Skonieczna5, Karl Mercieca6, Maurizio Digiuni7, Mehmet C Mocan8, Sergio Mahave9, Sabina Andersson10, David F Garway-Heath4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26104787      PMCID： PMC4592967          DOI： 10.1093/ajh/hpv096

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN： 0895-7061            Impact factor:   2.689


× No keyword cloud information.
  5 in total

Review 1.  The association of blood pressure and primary open-angle glaucoma: a meta-analysis.

Authors:  Di Zhao; Juhee Cho; Myung Hun Kim; Eliseo Guallar
Journal:  Am J Ophthalmol       Date:  2014-05-28       Impact factor: 5.258

Review 2.  Circadian Variation in Arterial Blood Pressure and Glaucomatous Optic Neuropathy--A Systematic Review and Meta-Analysis.

Authors:  Andrea Bowe; Michael Grünig; Jens Schubert; Münevver Demir; Vera Hoffmann; Fabian Kütting; Agnes Pelc; Hans-Michael Steffen
Journal:  Am J Hypertens       Date:  2015-03-11       Impact factor: 2.689

3.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 4.  Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects.

Authors:  Claudio Cedrone; Raffaele Mancino; Angelica Cerulli; Massimo Cesareo; Carlo Nucci
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

Review 5.  24-hour intraocular pressure and ocular perfusion pressure in glaucoma.

Authors:  Luciano Quaranta; Andreas Katsanos; Andrea Russo; Ivano Riva
Journal:  Surv Ophthalmol       Date:  2013 Jan-Feb       Impact factor: 6.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.